55 - IDSA Case-based Clinical Guideline Overview and Update

Speaker(s)

• 

  Paul AUWAERTER, MD

  Clinical Director, Professor of Medicine
  Johns Hopkins University School of Medicine
  Lutherville, MD

  Disclosure: Adaptive Biotechnologies : Consultant (Status: Terminated --- ); DiaSorin () : Consultant; Johnson and Johnson () : Shareholder; Medical-legal consulting : Consultant (Status: Ongoing); MicroB-Plex () : Scientific Research Study Investigator; Shionogi () : Consultant
• CD

  Charles Daley, MD

  Professor and Chief, Division of Mycobacterial and Respiratory Infections
  National Jewish Health
  Denver, CO

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Stuart Johnson, MD

  ID Physician and Researcher
  Hines VA Hospital
  Hines, Illinois

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-476-H01-P

Learning Objectives:

• cite the benefits of using of monoclonal antibody for C difficile infection
• apply new Lyme guideline recommendations to patient care
• discuss approaches to management of Nontuberculous Mycobacterial Diseases

Presentations:

• 2:45pm – 4:00pm EDT

  Clinical Overview and Update on Nontuberculous Mycobacterial Diseases
  Charles L. Daley, MD – National Jewish Health
• 2:45pm – 4:00pm EDT

  Focused Update on C. difficile infection Treatment Guidelines; Fidaxomicin and Bezlotoxumab
  Stuart Johnson, MD – Hines VA Hospital
• 2:45pm – 4:00pm EDT

  New Lyme Guidelines
  Paul AUWAERTER, MD – Johns Hopkins University School of Medicine